Zevalin Websites
ZEVALIN® » Learn about ZEVALIN | ZEVALIN® (ibritumomab tiuxetan)
ZEVALIN is a CD20-directed radiotherapeutic antibody administered as part of the ZEVALIN therapeutic regimen indicated for the treatment of patients with:Relapsed or refractory, low-grade or follicular B-cell non-Hodgkin's lymphoma (NHL). Previously untreated follicular NHL who achieve a partial or complete response to
13,401,393
$
8.95
Spectrum Pharmaceuticals, Inc. A Global Commercial-Stage Biotechnology
Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company
17,380,547
$
8.95
International Patient and Physician Summits on Waldenström's Macroglo
Not Applicable
$
8.95
